Endeavor

Moffitt Clinical Trials Offer Hope for Cervical Cancer Patients

“I’m living a normal life,” says one trial participant

Moffitt Launches Innovative Trial for Brain-Metastatic Breast Cancer

The therapy includes a three-part immunotherapy combination to shrink tumors.

The Power of CAR T in Solid Tumor Treatment

CAR T therapy involves a patient’s own T cells that have been genetically engineered to target a patient’s own specific cancer.

‘A Clinical Trial Saved My Life’

After melanoma metastasized to his brain, Larry Thomason was given 10 months to live.

Clinical Trial Brings Hope to Lung Cancer Patient

Last year, Lee was diagnosed with stage 4 metastatic lung cancer that had spread to her brain and spine.

Clinical Research and Patient Safety

As a National Cancer Institute-designated cancer center, Moffitt is charged with conducting investigator-initiated trials, which are designed and managed by the cancer center’s clinical faculty.

Clinical Research Unit: A Source of Hope

Look in Moffitt’s Clinical Research Unit (CRU), and you’ll find it in the work of a united team doing whatever is necessary to transform hope into reality in the form of cures.

Herpes Virus Can be Used to Treat Melanoma. Which Cancer is Next?

Since the approval of talimogene laherparepvec (T-VEC, Imlygic®) in 2015, Moffitt has been using this modified form of the herpes virus as a standard treatment for melanoma patients.

Saving Lives After Death

Gail Porter was the first patient to enroll in Moffitt's rapid tissue donation program.